Accessibility Menu

McKesson(FRA) MCK

Market Cap€88.45BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€764.39
+0.87%
+6.59Today

McKesson Financials at a Glance

Market Cap

€88.45BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€352.41K

Net Income (TTM)

€4.54K

EPS (TTM)

€32.02

P/E Ratio

23.69

Dividend

€2.82

Beta (Volatility)

-0.02 (Low)

Price

€764.39

Volume

0

Open

€764.39

Previous Close

€764.39

Daily Range

€764.39 - €764.39

52-Week Range

€583.20 - €865.80

Estimated Earnings Date

N/A

MCK News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About McKesson

McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products, provides practice management, technology, clinical support, and business solutions to community-based oncology, and other specialty practices, and sells financial, operational, and clinical solutions to pharmacies and provides consulting, outsourcing, technological, and other services. The International segment provides distribution and services to wholesale, institutional, and retail customers in European countries and Canada. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The RxTS segment brings together CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation, including Multi-Client Central Fill as a Service, to serve biopharma and life sciences partners and patients. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

Industry

Healthcare Providers and Services

Employees

43,000

CEO

Brian Scott Tyler, PhD

MCK Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

4.22%

Dividend Yield

0.37%

Payout Ratio

N/A

Stock Overview

Market Cap

€88.45BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

116.59M

Volume

0

Avg. Volume

1.727

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

McKesson Performance Analysis

McKesson annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31EUR 266,010,948,54117.0%
20242024-03-31EUR 284,944,534,9787.1%
20252025-03-31EUR 334,449,532,59617.4%
20262026-03-31EUR 348,167,792,8214.1%
McKesson annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31EUR 24.07286.7%
20242024-03-31EUR 20.65-14.2%
20252025-03-31EUR 23.9616.0%
20262026-03-31EUR 33.1238.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€90.63K

+1.1%

Gross Profit

€3.00K

+1.1%

Gross Margin

3.31%

+1.0%

Market Cap

€88.45BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€1.78

N/A

Employees

43,000

N/A

Net Income

€887.58

+1.2%

EBITDA

€1.39K

+1.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€14.83K

+38.0%

Total Debt

€10.23K

+1.2%

Accounts Receivable

€26.52K

+1.1%

Inventory

€22.97K

+1.1%

Long Term Debt

€8.84K

+1.2%

Short Term Debt

€1.39K

+1.1%

Return on Assets

5.37%

+1.2%

Return on Invested Capital

71.29%

N/A

Free Cash Flow

-€285.54

+0.3%

Operating Cash Flow

-€189.21

+0.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About MCK

What is the current price of McKesson?

McKesson is trading at €764.39 per share.

What is the 52-week range for McKesson?

Over the past 52 weeks, McKesson has traded between €583.20 and €865.80.

How much debt does McKesson have?

As of the most recent reporting period, McKesson reported total debt of €10.23B.

How much cash does McKesson have on hand?

McKesson reported €4.60B in cash and cash equivalents in its most recent financial results.

What is McKesson’s dividend yield?

McKesson currently has a dividend yield of 0.37%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.